Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives

Treatment-resistant schizophrenia (TRS) often results in severe disability and functional impairment. Currently, the diagnosis of TRS is largely exclusionary and emphasizes the improvement of symptoms that may not be detected early and treated according to TRS guideline. As the gold standard, clozap...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Shimeng, Cao, Ting, Cai, Hualin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597880/
https://www.ncbi.nlm.nih.gov/pubmed/36313375
http://dx.doi.org/10.3389/fphar.2022.1005702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597880/
https://www.ncbi.nlm.nih.gov/pubmed/36313375
http://dx.doi.org/10.3389/fphar.2022.1005702

Ejemplares similares